🟢 ClearOne is trading 6.7% up today in after-hours trading on Vivani's expected October 2026 merger closing

ClearOne is trading 6.7% up now at $4.41 after Vivani Medical said pricing and closing of the Cortigent reverse merger are expected in October 2026.

• The timeline provides a nearer-term catalyst for the neurotechnology transition and likely drove renewed interest.
• ClearOne fell from $4.99 on September 11 to $4.13 at the September 17 close.
• The Nasdaq rose 1.68% in a broader risk-on session, supporting sentiment.